공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 항체약물복합체(ADC) 시장(2021년) : COVID-19에 의한 성장과 변화(-2030년)

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028862
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,919,000 PDF (Single User License)
US $ 7,500 ₩ 8,878,000 PDF (Site License)
US $ 10,000 ₩ 11,838,000 PDF (Enterprise License)


세계의 항체약물복합체(ADC) 시장(2021년) : COVID-19에 의한 성장과 변화(-2030년) Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 항체약물복합체(ADC : Antibody Drug Conjugates) 시장에 대해 조사 분석했으며, 시장 특징, 시장 규모와 성장률, 시장 세분화, 지역별·국가별 내역, 경쟁 상황, 시장 점유율, 동향과 전략에 대한 체계적인 정보를 제공합니다.

목차

제1장 주요 요약

제2장 항체약물복합체(ADC) 시장 특징

제3장 항체약물복합체(ADC) 시장 동향과 전략

제4장 항체약물복합체(ADC)에 대한 COVID-19의 영향

제5장 항체약물복합체(ADC) 시장 규모와 성장률

  • 세계의 항체약물복합체(ADC) 시장 실적(금액)
  • 세계의 항체약물복합체(ADC) 시장 예측(금액)

제6장 항체약물복합체(ADC) 시장 세분화

  • 세계의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 단일클론항체
  • 링커
  • 약물/독소
  • 기타
  • 세계의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 혈액암
  • 유방암
  • 난소암
  • 폐암
  • 뇌종양
  • 기타
  • 세계의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)
  • Adcertis
  • Kadcyla
  • 기타
  • 세계의 항체약물복합체(ADC) 시장 : 기술별, 실적과 예측(금액)
  • Immunogen 기술
  • Seattle Genetics 기술
  • Immunomedics 기술
  • 기타
  • 세계의 항체약물복합체(ADC) 시장 : 최종사용자별, 실적과 예측(금액)
  • 병원
  • 클리닉
  • 기타

제7장 항체약물복합체(ADC) 시장 지역별·국가별 분석

  • 세계의 항체약물복합체(ADC) 시장 : 지역별, 실적과 예측(금액)
  • 세계의 항체약물복합체(ADC) 시장 : 국가별, 실적과 예측(금액)

제8장 아시아태평양의 항체약물복합체(ADC) 시장

  • 아시아태평양의 항체약물복합체(ADC) 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 정책, 규제, 규제기관, 주요 협회, 과세, 법인세 구조, 투자, 주요 기업
  • 아시아태평양의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 아시아태평양의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 아시아태평양의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제9장 중국의 항체약물복합체(ADC) 시장

  • 중국의 항체약물복합체(ADC) 시장 개요
  • 중국의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 중국의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 중국의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제10장 인도의 항체약물복합체(ADC) 시장

  • 인도의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 인도의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 인도의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제11장 일본의 항체약물복합체(ADC) 시장

  • 일본의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 일본의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 일본의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제12장 호주의 항체약물복합체(ADC) 시장

  • 호주의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 호주의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 호주의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제13장 인도네시아의 항체약물복합체(ADC) 시장

  • 인도네시아의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 인도네시아의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 인도네시아의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제14장 한국의 항체약물복합체(ADC) 시장

  • 한국의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 한국의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 한국의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제15장 서유럽의 항체약물복합체(ADC) 시장

  • 서유럽의 항체약물복합체(ADC) 시장 개요
  • 서유럽의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 서유럽의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 서유럽의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제16장 영국의 항체약물복합체(ADC) 시장

  • 영국의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 영국의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 영국의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제17장 독일의 항체약물복합체(ADC) 시장

  • 독일의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 독일의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 독일의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제18장 프랑스의 항체약물복합체(ADC) 시장

  • 프랑스의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 프랑스의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 프랑스의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제19장 동유럽의 항체약물복합체(ADC) 시장

  • 동유럽의 항체약물복합체(ADC) 시장 개요
  • 동유럽의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 동유럽의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 동유럽의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제20장 러시아의 항체약물복합체(ADC) 시장

  • 러시아의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 러시아의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 러시아의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제21장 북미의 항체약물복합체(ADC) 시장

  • 북미의 항체약물복합체(ADC) 시장 개요
  • 북미의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 북미의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 북미의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제22장 미국의 항체약물복합체(ADC) 시장

  • 미국의 항체약물복합체(ADC) 시장 개요
  • 미국의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 미국의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 미국의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제23장 남미의 항체약물복합체(ADC) 시장

  • 남미의 항체약물복합체(ADC) 시장 개요
  • 남미의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 남미의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 남미의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제24장 브라질의 항체약물복합체(ADC) 시장

  • 브라질의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 브라질의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 브라질의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제25장 중동의 항체약물복합체(ADC) 시장

  • 중동의 항체약물복합체(ADC) 시장 개요
  • 중동의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 중동의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 중동의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제26장 아프리카의 항체약물복합체(ADC) 시장

  • 아프리카의 항체약물복합체(ADC) 시장 개요
  • 아프리카의 항체약물복합체(ADC) 시장 : 종류별, 실적과 예측(금액)
  • 아프리카의 항체약물복합체(ADC) 시장 : 적응별, 실적과 예측(금액)
  • 아프리카의 항체약물복합체(ADC) 시장 : 제품별, 실적과 예측(금액)

제27장 항체약물복합체(ADC) 시장 경쟁 상황과 기업 개요

  • 항체약물복합체(ADC) 시장 경쟁 상황
  • 항체약물복합체(ADC) 시장 기업 개요
    • Bayer AG
    • Concortis Biotherapeutics
    • F. Hoffman-La Roche Ltd.
    • Immunomedics, Inc.
    • Oxford BioTherapeutics

제28장 항체약물복합체(ADC) 파이프라인 분석

제29장 항체약물복합체(ADC) 시장의 주요 M&A

제30장 항체약물복합체(ADC) 시장 향후 전망과 잠재적 분석

제31장 부록

KSM 21.10.13

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antibody drug conjugates market.

The report focuses on the antibody drug conjugates market which is experiencing strong growth. The report gives a guide to the antibody drug conjugates market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antibody drug conjugates? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antibody Drug Conjugates Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin; Others

2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Others

3) By Product: Adcertis; Kadcyla; Others

4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology; Others

5) By End User: Hospital; Clinics; Others

Companies Mentioned: Bayer AG; Concortis Biotherapeutics; F. Hoffman-La Roche Ltd.; Immunomedics; Oxford BioTherapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Antibody Drug Conjugates Market Characteristics

3. Antibody Drug Conjugates Market Trends And Strategies

4. Impact Of COVID-19 On Antibody Drug Conjugates

5. Antibody Drug Conjugates Market Size And Growth

  • 5.1. Global Antibody Drug Conjugates Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Antibody Drug Conjugates Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Antibody Drug Conjugates Market Segmentation

  • 6.1. Global Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monoclonal Antibodies
  • Linker
  • Drug/Toxin
  • Others
  • 6.2. Global Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Blood Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Brain Tumor
  • Others
  • 6.3. Global Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Adcertis
  • Kadcyla
  • Others
  • 6.4. Global Antibody Drug Conjugates Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Immunogen Technology
  • Seattle Genetics Technology
  • Immunomedics Technology
  • Others
  • 6.5. Global Antibody Drug Conjugates Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital
  • Clinics
  • Others

7. Antibody Drug Conjugates Market Regional And Country Analysis

  • 7.1. Global Antibody Drug Conjugates Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Antibody Drug Conjugates Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Antibody Drug Conjugates Market

  • 8.1. Asia-Pacific Antibody Drug Conjugates Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.4. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Antibody Drug Conjugates Market

  • 9.1. China Antibody Drug Conjugates Market Overview
  • 9.2. China Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.4. China Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Antibody Drug Conjugates Market

  • 10.1. India Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.3. India Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Antibody Drug Conjugates Market

  • 11.1. Japan Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.3. Japan Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Antibody Drug Conjugates Market

  • 12.1. Australia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.3. Australia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Antibody Drug Conjugates Market

  • 13.1. Indonesia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.3. Indonesia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Antibody Drug Conjugates Market

  • 14.1. South Korea Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.3. South Korea Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Antibody Drug Conjugates Market

  • 15.1. Western Europe Antibody Drug Conjugates Market Overview
  • 15.2. Western Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.4. Western Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Antibody Drug Conjugates Market

  • 16.1. UK Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.3. UK Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Antibody Drug Conjugates Market

  • 17.1. Germany Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.3. Germany Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Antibody Drug Conjugates Market

  • 18.5. France Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.6. France Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.7. France Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Antibody Drug Conjugates Market

  • 19.1. Eastern Europe Antibody Drug Conjugates Market Overview
  • 19.2. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.4. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Antibody Drug Conjugates Market

  • 20.1. Russia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.3. Russia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Antibody Drug Conjugates Market

  • 21.1. North America Antibody Drug Conjugates Market Overview
  • 21.2. North America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.4. North America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Antibody Drug Conjugates Market

  • 22.1. USA Antibody Drug Conjugates Market Overview
  • 22.2. USA Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.4. USA Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Antibody Drug Conjugates Market

  • 23.1. South America Antibody Drug Conjugates Market Overview
  • 23.2. South America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.4. South America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Antibody Drug Conjugates Market

  • 24.1. Brazil Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.3. Brazil Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Antibody Drug Conjugates Market

  • 25.1. Middle East Antibody Drug Conjugates Market Overview
  • 25.2. Middle East Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.4. Middle East Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Antibody Drug Conjugates Market

  • 26.1. Africa Antibody Drug Conjugates Market Overview
  • 26.2. Africa Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.4. Africa Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Antibody Drug Conjugates Market Competitive Landscape And Company Profiles

  • 27.1. Antibody Drug Conjugates Market Competitive Landscape
  • 27.2. Antibody Drug Conjugates Market Company Profiles
    • 27.2.1. Bayer AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Concortis Biotherapeutics
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. F. Hoffman-La Roche Ltd.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Immunomedics, Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Oxford BioTherapeutics
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Antibody Drug Conjugates Pipeline Analysis

29. Key Mergers And Acquisitions In The Antibody Drug Conjugates Market

30. Antibody Drug Conjugates Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q